Amedisys (NASDAQ: AMED) reported Q3 EPS of $1.15, $0.26 better than the analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE